CR11509A - Polvo nutricional estable - Google Patents

Polvo nutricional estable

Info

Publication number
CR11509A
CR11509A CR11509A CR11509A CR11509A CR 11509 A CR11509 A CR 11509A CR 11509 A CR11509 A CR 11509A CR 11509 A CR11509 A CR 11509A CR 11509 A CR11509 A CR 11509A
Authority
CR
Costa Rica
Prior art keywords
nutritional powder
stable nutritional
stable
lecithin
oils
Prior art date
Application number
CR11509A
Other languages
English (en)
Inventor
Jeffrey M Boff
Christine L Clinger
Marti Bergana
Paul W Johns
Gary E Katz
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of CR11509A publication Critical patent/CR11509A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Dairy Products (AREA)

Abstract

Los datos colectivos de los estudios demuestran que la proteina de caseina hidrolizada en combinacion con la lecitina segun se describe aqui, suministra un efecto antioxidante sinergico tanto en una matriz de mezcla de aceites como de polvo nutricional
CR11509A 2007-12-20 2010-06-17 Polvo nutricional estable CR11509A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1531207P 2007-12-20 2007-12-20

Publications (1)

Publication Number Publication Date
CR11509A true CR11509A (es) 2010-12-16

Family

ID=40788960

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11509A CR11509A (es) 2007-12-20 2010-06-17 Polvo nutricional estable

Country Status (27)

Country Link
US (1) US8361534B2 (es)
EP (1) EP2227099B1 (es)
JP (1) JP2011507517A (es)
CN (1) CN101998835A (es)
AR (1) AR069839A1 (es)
AU (1) AU2008343687A1 (es)
BR (1) BRPI0823502A2 (es)
CA (1) CA2708272C (es)
CL (1) CL2008003807A1 (es)
CO (1) CO6280446A2 (es)
CR (1) CR11509A (es)
DK (1) DK2227099T3 (es)
DO (1) DOP2010000174A (es)
EC (1) ECSP10010261A (es)
ES (1) ES2535144T3 (es)
GT (1) GT201000174A (es)
HK (1) HK1145275A1 (es)
IL (1) IL206200A (es)
MX (1) MX2010006891A (es)
MY (1) MY150500A (es)
NZ (1) NZ585574A (es)
PA (1) PA8808801A1 (es)
PE (1) PE20091454A1 (es)
RU (1) RU2479219C2 (es)
TW (1) TWI418308B (es)
WO (1) WO2009085386A2 (es)
ZA (1) ZA201004029B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1973406T3 (da) 2005-12-28 2014-06-23 Advanced Bionutrition Corp Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
JP5285617B2 (ja) 2006-12-18 2013-09-11 アドバンスド バイオニュートリション コーポレーション 生きたプロバイオティクスを含む乾燥食物製品
CA2756883C (en) 2009-03-27 2018-01-09 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
MX2011011538A (es) 2009-04-29 2012-06-13 Amarin Pharma Inc Composicion farmaceutica estable y metodos de uso de la misma.
NZ720946A (en) 2009-04-29 2017-09-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
RU2567668C2 (ru) * 2009-05-26 2015-11-10 Эдванст Бионутришн Корпорейшн Стабильная сухая порошкообразная композиция, содержащая биологически активные микроорганизмы и/или биоактивные материалы, и способ ее изготовления
SI3318255T1 (sl) 2009-06-15 2021-07-30 Amarin Pharmaceuticals Ireland Limited Kompozicije in metode za zdravljenje kapi pri subjektu, ki prejema sočasno zdravljenje s statinom
TW201112967A (en) * 2009-09-16 2011-04-16 Abbott Lab Dryblended nutritional powders
CA2775339C (en) 2009-09-23 2017-03-28 Amarin Corporation Plc Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
NZ601017A (en) 2010-01-28 2014-07-25 Advanced Bionutrition Corp Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
RS57588B1 (sr) 2010-08-13 2018-11-30 Advanced Bionutrition Corp Supstanca za stabilizaciju bioloških materijala za suvo skladištenje
AU2011336856A1 (en) 2010-11-29 2013-07-04 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
TWI561175B (en) * 2011-03-31 2016-12-11 Meiji Co Ltd Flowable nutrition composition containing l-arginine and method for producing the same
US20120269929A1 (en) * 2011-04-22 2012-10-25 Hugh Lippman Fortified Milk-Based Nutritional Compositions
EP2744357A2 (en) * 2011-08-16 2014-06-25 Abbott Laboratories Use of ultrasonic energy in the production of nutritional powders
EP2757898B1 (en) 2011-09-20 2015-10-21 Abbott Laboratories Powdered nutritional formulations including spray-dried plant protein
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
WO2013103958A1 (en) 2012-01-06 2013-07-11 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
MX2020013922A (es) 2012-06-29 2022-08-15 Amarin Pharmaceuticals Ie Ltd Metodos para reducir riesgo de evento cardiovascular en sujeto con terapia con estatina.
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US20140328970A1 (en) * 2013-05-03 2014-11-06 Mead Johnson Nutrition Company Nutritional Composition Comprising Whey and Hydrolyzed Casein and Uses Thereof
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10639334B2 (en) 2014-01-07 2020-05-05 Mead Johnson Nutrition Company Pediatric nutritional composition with milk peptides for healthy growth and development
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US20170202260A1 (en) * 2014-07-21 2017-07-20 Abbott Laboratories Nutritional powder with specific antioxidants
SG11201702834WA (en) * 2014-10-08 2017-05-30 Abbott Lab Nutritional compositions comprising an oxidizable component and water-soluble plant extract
WO2017019273A1 (en) 2015-07-29 2017-02-02 Advanced Bionutrition Corporation Stable dry probiotic compositions for special dietary uses
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
WO2019090093A1 (en) * 2017-11-03 2019-05-09 Advanced Bionutrition Corp. Composition containing viable microorganisms and methods of making
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
MA51766A (fr) 2018-09-24 2020-12-16 Amarin Pharmaceuticals Ie Ltd Procédés de réduction du risque d'événements cardiovasculaires chez un sujet
KR20240012390A (ko) 2021-04-21 2024-01-29 애머린 파마슈티칼스 아일랜드 리미티드 심부전의 위험을 감소시키는 방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830861A (en) * 1988-07-14 1989-05-16 Bristol-Myers Company Low manganese high protein rice flour
US5013569A (en) * 1990-05-21 1991-05-07 Century Laboratories, Inc. Infant formula
US5021245A (en) 1990-05-22 1991-06-04 Abbott Laboratories Infant formula containing a soy polysaccharide fiber source
US5405637A (en) * 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
US6136858A (en) 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
ATE409483T1 (de) * 1994-01-10 2008-10-15 Abbott Lab Enterale zusammensetzung mit ribo-nucleotiden
JP3878690B2 (ja) * 1995-09-29 2007-02-07 森永乳業株式会社 乳幼児用乳糖含有食品組成物
DE69823548T2 (de) 1997-02-21 2005-02-24 Abbott Laboratories, Abbott Park Verwendung von mehrfach ungesättigten fettsäuren zur vorbeugung von nekrotizierender enterokolitis
EP1034704A1 (en) 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6207638B1 (en) * 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
ES2291406T3 (es) 2001-11-26 2008-03-01 Nestec S.A. Composicion nutritiva auto-estable, que contiene proteina de suero lacteo, intacta, procedimiento de fabricacion y uso.
RU2262867C2 (ru) * 2002-02-14 2005-10-27 Катков Юрий Адольфович Бад к пище для улучшения репродукции человека (варианты)
TWI317636B (en) 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
US7090879B2 (en) 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
DE602005026456D1 (de) 2004-12-27 2011-03-31 Nestec Sa Verwendung von säuglingsnahrung mit reduziertem proteingehalt
US20070281054A1 (en) * 2006-05-31 2007-12-06 Abbott Laboratories Organic powder nutritional formula containing select carbohydrate combinations

Also Published As

Publication number Publication date
PE20091454A1 (es) 2009-10-25
MX2010006891A (es) 2010-10-15
HK1145275A1 (en) 2011-04-15
CA2708272C (en) 2015-10-13
PA8808801A1 (es) 2009-07-23
JP2011507517A (ja) 2011-03-10
WO2009085386A2 (en) 2009-07-09
TW200934396A (en) 2009-08-16
TWI418308B (zh) 2013-12-11
CL2008003807A1 (es) 2009-10-16
CO6280446A2 (es) 2011-05-20
RU2479219C2 (ru) 2013-04-20
GT201000174A (es) 2012-04-03
DK2227099T3 (en) 2015-06-15
US8361534B2 (en) 2013-01-29
MY150500A (en) 2014-01-30
IL206200A (en) 2015-05-31
IL206200A0 (en) 2010-12-30
RU2010129985A (ru) 2012-01-27
ES2535144T3 (es) 2015-05-06
AU2008343687A1 (en) 2009-07-09
WO2009085386A3 (en) 2009-09-17
ECSP10010261A (es) 2010-07-30
CN101998835A (zh) 2011-03-30
AR069839A1 (es) 2010-02-24
EP2227099A2 (en) 2010-09-15
US20090162521A1 (en) 2009-06-25
EP2227099B1 (en) 2015-03-04
DOP2010000174A (es) 2010-06-30
ZA201004029B (en) 2011-04-28
NZ585574A (en) 2012-06-29
BRPI0823502A2 (pt) 2018-03-20
CA2708272A1 (en) 2009-07-09

Similar Documents

Publication Publication Date Title
CR11509A (es) Polvo nutricional estable
CR20110508A (es) Nuevos derivados de prolina como inhibidores de catepsina
CR11508A (es) Polvo nutricional estable
AR083720A1 (es) Formulaciones adhesivas de proteina con aditivos de epiclorohidrina e isocianato
BR112016028644A2 (pt) composições de célula t aprimoradas
PA8850201A1 (es) Combinaciones antitumorales que contienen anticuerpos
PA8850101A1 (es) Combinaciones antitumorales que contienen anticuerpos
CO6630181A2 (es) Composiciones y métodos para uso de anticuerpos terapéuticos de lrp6( proteina relacionada con lipoproteínas de baja densidad 6)
CO6450665A2 (es) Anticuerpos anti-fgfr3 y métodos que los utilizan
BR112013006769A2 (pt) combinação sinérgica de um anticorpo específico para cd38
CR11844A (es) Método y aparatos para identificar elecciones dieteticas
MX2010006197A (es) Composicion nutricional enterica liquida con alto contenido de energia.
AR066042A1 (es) Moleculas y metodos para modular la proteina convertasa-subtilisina /quexina tipo 9 (pcsk9)
EA201001845A1 (ru) Высокоэффективный антиокислитель на основе трегалулозы
AU201810529S (en) Lighting Module Heatsink
ECSP13013018A (es) Composiciones nutricionales fortificadas a base de leche
BR112014014834A2 (pt) composições para cuidado oral
UY34800A (es) Combinaciones farmacéuticas que contienen un inhibidor de 11-beta-hidroxiesteroide dehidrogenasa-1 útil en trastornos metabólicos
BR112013027403A2 (pt) composições que compreendem uma antimetabólito de glicose e selênio
PH12015500049B1 (en) Novel protein material
WO2012142256A3 (en) Modulators of mitochondrial protein import
AU321504S (en) Clutch housing
ECSP13012464A (es) Alimento para alimentación acuícola
EA200601632A1 (ru) Новая комбинация гетероциклического соединения и антиоксиданта и фармацевтические композиции, которые её содержат
UA71085U (ru) Препарат для повышения иммунного потенциала и антиоксидантной защиты у глубокостельных коров "имувит"

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)